Bruce G. Allen Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$644K Buy
2,561
+263
+11% +$56.6K 0.41% 29
2026
Q1
$500K Sell
2,298
-131
-5% -$29.1K 0.33% 37
2025
Q4
$555K Buy
2,429
+149
+7% +$33.9K 0.38% 33
2025
Q3
$528K Sell
2,280
-130
-5% -$26.5K 0.38% 32
2025
Q2
$447K Sell
2,410
-332
-12% -$61.7K 0.34% 34
2025
Q1
$575K Sell
2,742
-205
-7% -$39.9K 0.45% 27
2024
Q4
$524K Buy
2,947
+2
+0.1% +$368 0.42% 31
2024
Q3
$582K Buy
2,945
+44
+2% +$8.21K 0.45% 31
2024
Q2
$498K Buy
2,901
+152
+6% +$25.2K 0.42% 36
2024
Q1
$501K Buy
2,749
+241
+10% +$41.5K 0.41% 36
2023
Q4
$389K Buy
+2,508
New +$366K 0.35% 41

Other funds holding ABBV

Bruce G. Allen Investments's ABBV Position: Q2 2026 in Review

Bruce G. Allen Investments increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $56.6K and bringing the position to 2,561 shares worth $644K. The position accounts for 0.41% of the portfolio, ranked #29.

Bruce G. Allen Investments first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bruce G. Allen Investments held 2,561 shares of AbbVie worth $644K as of Q2 2026.
  • Bruce G. Allen Investments bought 263 AbbVie shares in Q2 2026, an estimated $56.6K.
  • AbbVie made up 0.41% of Bruce G. Allen Investments's portfolio in Q2 2026, its #29 holding.
  • Bruce G. Allen Investments first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.